Business Overview of IBEX
IBEX Technologies Inc. is a publicly traded company listed on the TSX-Venture Exchange (IBT.V).
The Company operates principally through IBEX Pharmaceuticals Inc.
IBEX Pharmaceutical’s primary business is the manufacture and selling of high purity enzymes for in-vitro diagnostics and research. The Company also makes and sell osteoarthritis kits (ELISA’s) for pre-clinical research.
IBEX Pharmaceutical provides important services to major in-vitro companies some of which are acknowledged below:
- Seed Bank Creation
- Fermentation and Biotransformation
- Protein Purification
- Protein Formulation
- Filling of Device Components
- Lyophilization
- Seed Bank Creation
- Fermentation and Biotransformation
- Protein Purification
- Protein Formulation
- Filling of Device Components
- Lyophilization
The IBEX Pharmaceutical’s Quality Management System is certified ISO 13485:2016.
![fermentor-contract-manufacturing-600×500 fermentor-contract-manufacturing-600x500](https://www.ibex.ca/wp-content/uploads/2022/01/fermentor-contract-manufacturing-600x500-1.png)
Selected Diagnostic Partnerships
![Business Overview Business Overview](http://ibex.ca/wp-content/uploads/2017/09/haemonetics_logo-904x283.png)
![Business Overview Business Overview](http://ibex.ca/wp-content/uploads/2017/09/abbott-800x286.png)
![tem_265x100 tem_265x100](https://www.ibex.ca/wp-content/uploads/2017/09/tem_265x100.png)
![Business Overview Business Overview](http://ibex.ca/wp-content/uploads/2017/10/medtronic_logo-500x100.png)
![siemens_logo-150×99 siemens_logo-150×99](https://www.ibex.ca/wp-content/uploads/2017/09/siemens_logo-150x99-2-300x60.png)